CDK4 expression and activity are required for cytokine responsiveness in T cells

J F Modiano1, J Mayor, C Ball

  • 1Center for Cancer Causation and Prevention, AMC Cancer Research Center, Denver, CO 80214, USA. modianoj@amc.org

Insights

Cyclin-dependent kinase 4 (CDK4) is crucial for T cell responsiveness to interleukin-2 (IL-2). Its expression and activity are necessary for T cells to respond to cytokines, linking signaling to cell cycle progression.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • T cell activation via the antigen (Ag) receptor can result in either cytokine responsiveness or unresponsiveness.
  • Interleukin-2 (IL-2) is a key cytokine for T cell proliferation and function.
  • Cyclin-dependent kinases (CDKs) regulate cell cycle progression and are implicated in various cellular processes.

Purpose of the Study:

  • To investigate the role of cyclin-dependent kinase 4 (CDK4) in establishing and maintaining IL-2 responsiveness in human T cells.
  • To determine the relationship between CDK4 expression/activity and T cell cytokine response.
  • To explore the impact of T cell receptor (TCR) stimulation on CDK4 activity and IL-2 responsiveness.

Main Methods:

  • Analysis of CDK4 expression and activity in peripheral blood T cells and the IL-2-dependent Kit-225 T cell line.
  • Stimulation of T cells using mitogens, IL-2, and TCR-activating agents (PHA, anti-CD3, PMA).
  • Assessment of T cell proliferation in response to IL-2.
  • Manipulation of CDK4 activity using inhibitors (herbimycin A, staurosporine) and overexpression of CDK inhibitors (p16/Ink4-a, p21/Waf-1a) or a kinase-inactive CDK4 mutant.

Main Results:

  • CDK4 expression and activity, sensitive to herbimycin A and staurosporine, precede IL-2 responsiveness in mitogen-stimulated T cells.
  • A subset of unstimulated T cells (~30%) exhibited constitutive CDK4 expression/activity and IL-2 responsiveness, resistant to inhibitors.
  • In Kit-225 cells, TCR stimulation reduced CDK4 expression/activity, leading to IL-2 unresponsiveness, which could be mimicked by CDK inhibitors or a dominant-negative CDK4 mutant.

Conclusions:

  • CDK4 expression and activity are essential for inducing and maintaining T cell responsiveness to cytokines like IL-2.
  • CDK4 acts as a critical link between T cell signaling pathways and the cell cycle machinery controlling proliferation.
  • Aberrant regulation of CDK4 may contribute to altered cytokine responsiveness in T cells.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...